PRRT2 and diabetic retinopathy: Considering the interrelationship between VEGF and PKC and their contribution to diabetic retinopathy, LAB might be a possible therapeutic option for the treatment of diabetic retinopathy per se or as an adjunct to anti-VEGF agents [41].